Bluebird Bio mispriced its sickle cell gene therapy and fumbled a pivotal financ...
During 2022, drugmakers substantially raised prices on eight widely used medicin...
Amid fears of superbugs, the sale of medically important antibiotics given to fo...
The approval of Bluebird Bio’s sickle cell treatment should have been a momentum...
The biotech industry has tried — and repeatedly failed — to develop new and effe...
A medical student and twin sister of a man with profound autism argues future do...
Vertex made history Friday when it received regulatory approval for a CRISPR-bas...
Hisamitsu Pharmaceutical saw the highest growth of 199% in patent filings and 26...
Lupin saw the highest growth of 199% in patent filings in August and 149% in gra...
Cosmo Pharmaceuticals saw the highest growth of 399% in patent filings and 499% ...
Otsuka saw the highest growth of 95% in patent filings in August and 104% in gra...
Daewoong saw the highest growth of 108% in patent filings in July and 266% in gr...
United Laboratories International saw the highest growth of 132% in patent filin...
Almirall saw the highest growth of 132% in patent filings in August and 99% in g...
Cipla saw the highest growth of 199% in patent filings in September and 99% in g...
Sun Pharmaceutical Industries saw the highest growth of 162% in patent filings i...